Riverside Partners Combines Sequoia Biotech Consulting and Syner-G BioPharma Group

September 18, 2024

Boston-based private equity firm Riverside Partners has combined two of its portfolio companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, into a single, integrated life‑sciences services business. The combined organization — bringing together regulatory, development, quality, and operational capabilities — has approximately 500 employees and will provide end-to-end solutions to pharmaceutical, biotechnology, and medical device clients.

Buyers
Riverside Partners, LLC
Targets
Sequoia Biotech Consulting, Syner-G BioPharma Group
Location
United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.